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ABSTRACT 
This study investigates the effects of drug-loaded nanofibers on the solubility of the poorly 
water-soluble drug, loratadine. Amorphous morphologies of electrospun loratadine nanofibers 
were prepared using a low-cost 3D-printed electrospinning setup with counter-flow air for the 
rapid production of nanofibers . Polyvinylpyrrolidone was used as a carrier polymer and ethanol 
as a solvent in the solution preparation. The prepared nanofibers were characterized by scanning 
electron microscopy, differential scanning calorimetry, X-ray diffraction analysis, Fourier 
transform infrared spectroscopy, solubility and in vitro dissolution studies with kinetic behavior 
evaluation. The scanning electron microscope images showed smooth nanofiber surfaces with 
a mean diameter of 372 nm. Moreover, both differential scanning calorimetry and X-ray 
diffraction analysis confirmed the amorphous state of the prepared nanofibers. FT-IR results 
suggested that loratadine lost its original crystal structure by hydrogen bonding interactions. 
The fabricated nanofibrous drug samples demonstrated a remarkable 26-fold increase in 
solubility when compared to the pure drug in phosphate buffer at pH 7.4. Furthermore, 
dissolution studies showed that 66% of the drug from the nanofibrous mat was released in the 
first 10 min, which is significantly higher than the maximum of 4% drug release of the reference 
samples within the same time. Thus, Loratadine nanofibers can be considered as an alternative 
dosage form with improved physicochemical properties.
Keywords: Electrospinning, 3D printing, Nanofibers, Loratadine, Physicochemical analysis
1. INTRODUCTION
Loratadine (LOR) is a second-generation anti-histamine (H1) agent. It is frequently prescribed 
to treat allergic disorders without a central nervous system depressant effects (Simons, 2002). 
LOR belongs to class II of the biopharmaceutical classification system that exhibits a poor water 
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solubility (0.00303 mg mL-1) and high permeability (log P of 5) (Dagenais et al., 2009). From 
the chemical point of view, LOR contains pyridine nitrogen atom that is responsible for its pH-
dependent solubility (Han et al., 2004). Its pKa value at 25 ºC has been reported as 4.85–6.00 
(Dagenais et al., 2009; Han et al., 2004; Omar et al., 2007). Related to the properties mentioned 
above, LOR shows low and variable bioavailability (Arya et al., 2012). Many possibilities have 
been applied to enhance the dissolution and solubility of LOR, which includes solid dispersion, 
inclusion with ß-cyclodextrin derivatives, micellar solubilization and self-microemulsifying 
drug systems (Frizon et al., 2013; Li et al., 2015; Nacsa et al., 2009, 2008).
In recent years, many efforts have been devoted to utilizing nanoparticle design for increasing 
the bioavailability of drugs. Preparation of LOR nanoparticles has been shown to enhance its 
dissolution and solubility (Alshweiat et al., 2018; Rodriguez Amado et al., 2017). The use of 
nanoparticles to produce LOR with increased hydrophilic properties shows promise and has 
opened the scope for new methods of preparation and administrations (Akhgari et al., 2016). 
Nanofibers, due to their architecture, are considered to be a sophisticated solution to the current 
inconveniences of drug delivery (Li et al., 2015). Drugs based on nanofibers show faster 
dissolution kinetics than their micron-sized counterparts, as nanofibers have a significantly 
higher surface area to volume ratio (Jiang et al., 2004).
Among different method of preparation, electrospinning is considered as the most efficient 
process in nanofiber production. This process has been recognized as simple and versatile to 
produce nanofibers with low cost (Huang et al., 2003). Radacsi et al. (Radacsi et al., 2018) 
reported the benefits of electrospinning on scaling up to high yield. This feature makes 
electrospinning attractive for the industry over the electrospray technique. Both methods are 
based on electrohydrodynamic atomization and have been demonstrated to improve the 
physicochemical properties of drug particles (Ambrus et al., 2013; Radacsi et al., 2019).
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The poor water solubility of the active pharmaceutical ingredients (APIs) and candidates is one 
of the major challenges of the pharmaceutical industry (Craig, 2002). The delivery of these 
agents is associated with poor bioavailability (Amidon et al., 1995). As a novel drug 
manufacturing method, electrospinning is mainly focused on enhancing the dissolution of 
poorly water-soluble drugs. The enhanced dissolution of drugs in the nanofibers are related to 
the presence of the amorphous state, high specific surface area, increased wettability and 
solubility, and lower precipitation. This offers alternative drug delivery methods, e.g. the 
electrospun drug films can be used for transdermal delivery, or it can dissolve in the oral cavity 
(e.g. sublingual or buccal administration), which can be advantageous for patients that cannot 
swallow. Furthermore, the advanced bioavailability also reduces the side-effects of the drugs.
Recently, academic and industrial efforts have concentrated on enhancing the dissolution of the 
poorly water-soluble pharmaceutical agents by electrospinning technology. The fabrication of 
itraconazole nanofibers using the co-polymer PVPVA64 as a carrier was done by a novel high-
speed electrospinning method (Nagy et al., 2015). The produced amorphous nanofibers showed 
rapid dissolution, 90% of the drug was dissolved within 10 min. The high-speed electrospinning 
method has a significantly higher production rate than the conventional electrospinning 
techniques, making it attractive for industrial pharmaceutical manufacturing. In another study, 
electrospinning of itraconazole was performed with hydroxypropylmethylcellulose as a carrier 
polymer was performed (Verreck et al., 2003). The authors highlighted the amorphous structure 
and the rapid and complete dissolution of the API, itraconazole, from the prepared nanofibers. 
Electrospinning has been utilized in poorly water-soluble analgesics. Ketoprofen showed a 
significant dissolution rate increase from the prepared nanofibers with PVP K30 as a carrier 
polymer. The complete drug release was achieved within just 30 min, while the pure drug form 
showed approximately 5% release after 2 h (Yu et al., 2010). Moreover, niflumic acid-loaded 
nanofibers into PVP (Mw 1,300,000 g mol-1) were incorporated into capsules. The formulations 
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showed a drug release of 69-91% after just 15 min (Radacsi et al., 2019). The high drug release 
rate from nanofibers was also achieved in acetaminophen. Yu et al (Yu et al., 2010) found that 
93.8% of poorly water-soluble acetaminophen was released in the first 2 min from the PVP (Mw 
360,000 g mol-1) drug-loaded nanofibers. Furthermore, ibuprofen has been fabricated into 
nanofibers by using electrospinning (Potrč et al., 2015). The nanofibers released 100% of the 
ibuprofen in 4 h. 
To prepare nanofibers of the poorly water-soluble plant sterol, researchers fabricated β-
sitosterol-loaded chitosan nanofibers (Paaver et al., 2016). The prepared nanofibers exhibited 
freely water-soluble properties with a very short lag-time in releasing the β-sitosterol. In a study 
by Li et al (Li et al., 2013), improved dissolution rates have been achieved for caffeine and 
riboflavin nanofibers, using polyvinyl alcohol polymer as filament-forming polymer and drug 
carrier. The nanofibers showed 100% and 40% release of caffeine and riboflavin, respectively 
within just 60 s. 
In comparison to the conventional processes of solid dispersion fabrication, electrospinning can 
produce nanofibers with enhanced dissolution compared to film casting (Potrč et al., 2015) 
freeze-drying, vacuum drying, and heating drying (Yu et al., 2010).
Many studies discussed the effects of the material and process parameters of electrospinning on 
the release of poorly water-soluble drugs from the nanofibers. These parameters include; drug 
characteristics (Potrč et al., 2015), polymer type (Baskakova et al., 2016), drug and polymer 
ratios (Brewster et al., 2004), solvents type and ratios (Paaver et al., 2016), in addition to the 
electrospinning parameters of voltage (Verreck et al., 2003), flow rate, or distance between the 
collector and the spinneret (Radacsi et al., 2019).
The material properties affect the properties of the electrospinning solution, such as viscosity, 
conductivity, and surface tension, thus the morphology and size of the electrospun nanofibers 
can be controlled by designing the solution (Fong et al., 1999). In general, concentration is a 
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critical factor determining the solution viscosity, whereas polymer and solvent affect the value 
of the surface tension (Yang et al., 2004). Moreover, adjusting the process parameters has 
significant effects on controlling the final structure of the electrospun fibers (Ryu et al., 2003).
Polyvinylpyrrolidone (PVP) is a widely-used polymer for preparing electrospun fibers. It shows 
low toxicity, high biocompatibility and excellent solubility in most organic solvents 
(Chuangchote et al., 2009). Furthermore, PVP with the Mw 1,300,000 g mol-1 has been the most 
thoroughly investigated in reported studies related to electrospinning with PVP (Li and Xia, 
2003; Nuansing et al., 2006).
In the present study, a low-cost 3D-printed electrospinning setup with a counter-flow air stream 
is investigated as a rapid and inexpensive formulation method for the fabrication of 
nanostructured LOR. The size and morphology of the produced LOR-PVP nanofibers were 
characterized by scanning electron microscopy. The structure of the products was investigated 
using differential scanning calorimetry, X-ray powder diffraction and Fourier transform 
infrared spectroscopy. The solubility and in vitro release of the selected product was studied in 
a phosphate buffer solution at pH 7.4 and was compared with the corresponding physical 
mixture and a prepared reference sample.
2. Experimental
2.1 Materials
Loratadine (LOR) was purchased from Teva Ltd. (Budapest, Hungary). Polyvinylpyrrolidone 
(PVP; Mw 1,300,000 g mol-1) was purchased from Alfa Aesar, UK. 99.99% purity ethanol was 
obtained from Fisher Scientific, UK.
2.2. Solution preparation and electrospinning
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LOR: PVP at 1:1 ratio was used to prepare the electrospinning samples containing PVP as a 
carrier and ethanol as a solvent system. 0.77 g LOR was mixed with 0.77 g PVP, and this 
powder mixture was dissolved in 50 mL ethanol. The electrical conductivity of the solution was 
2 μS cm-1. This solution was sucked into a 60 mL syringe (BD plastics). The nanofibers were 
produced in a 3D-printed electrospinning setup (Figure 1). From the production point of view, 
this study describes the first application of a low-cost ($100 USD) 3D-printed electrospinning 
chamber made by the fused deposition modelling (FDM) method with a counter-flow air 
stream. The details of the 3D printing process, assembly of the electrospinning rig, and the .STL 
files of the electrospinning chamber can be found in another work (Huang et al., 2019). A 20G 
needle was applied at the tip of the syringe, and it was placed into the syringe pump (Cole-
Parmer, USA). The LOR solution was injected into the 3D-printed chamber through a Teflon 
tube using the automatic pump with a pumping speed of 15 μL min-1. The Teflon tube (inner 
diameter 0.8 mm) was connected to a blunt 20G needle that was placed inside the 3D-printed 
setup and was covered by a safety cap to prevent electric shock. The blunt nozzle was charged 
by a +35 kV DC high-voltage power supply (Information Unlimited, Amherst, USA) at its 
maximum voltage. The working distance (WD) between the spinneret and the fiber collector 
was set to either 65 or 95 mm (95 mm was the maximum distance possible in the setup without 
using extension parts). The fibers were collected on an 80 mm wide grounded stainless steel 
drum, which was rotating with a speed of 100 rpm. A constant stream of air (5.2 ms-1) was 
supplied into the chamber opposing the direction of the electrospun fibers, in order to increase 
the evaporation rate of the solvent from the electrospun jet and the fibers as they travelled across 
the chamber. Two different working distances between the injection nozzle and the collection 
drum were tested in the experiments, and all the other parameters were fixed. The experiments 
were performed at room temperature at the relative humidity of 42-49%. Each run lasted for 15 
minutes. 
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Figure 1. Schematic illustration of the 3D-printed modular electrospinning setup.
2.3 Preparation of the reference samples 
The reference samples, physical mixture (PM) and the solvent evaporated sample (SE), were 
prepared by two different methods to control the effect of polymer and re-crystallization 
procedure on the physicochemical properties of LOR. In the first method the physical mixture 
(PM) was prepared by Turbula mixer System (Schatz; Willy A. Bachofen AG Maschinenfabrik, 
Basel, Switzerland) of LOR and PVP with 1:1 ratio at 50 rpm for 10 min (PM). The second 
method involved the evaporative re-crystallization of the previously mixed PM which was 
dissolved in 100 mL ethanol. The solvent was evaporated at 25 ºC. The preparation methods of 
the nanofibers and reference samples are summarized in Table 1.
Table 1. Composition and method of preparation of loratadine nanofibers and reference samples.
Sample Abbreviation LOR (g) PVP (g) Method of preparation 
Raw loratadine LOR - - -
  
9
Physical mixture PM (1:1) 5 5 Turbula mixer 
(for 10 mins)
Re-crystallized PM from 
100 mL ethanol solution
SE (1:1) 5 5 Solvent evaporation 
(at 25 °C)
Loratadine-Nanofiber 
Experiment 1
LOR-NF1 5 5 Electrospinning method 
(WD = 65 mm)
Loratadine-Nanofiber 
Experiment 2
LOR-NF2 5 5 Electrospinning method 
(WD = 95 mm)
2.4 Scanning electron microscopy (SEM)
The morphological appearance of the electrospun fibers was investigated by scanning electron 
microscopy (SEM) (Hitachi S4700, Hitachi Scientific Ltd., Tokyo, Japan) at 10 kV. The 
samples were coated with gold-palladium (90 seconds) by a sputter coater (Bio-Rad SC 502, 
VG Microtech, Uckfield, UK). One hundred nanofibers were selected from each SEM image, 
and the mean fiber diameter was measured by ImageJ 1.44p software (NIH, USA). 
2.5 Differential scanning calorimetry (DSC)
Differential scanning calorimeter (Mettler Toledo TG 821e DSC; Mettler Inc., Schwerzenbach, 
Switzerland) was used to measure the thermal response of the samples. Approximately 3 – 5 
mg of the sample was precisely weighed into DSC sample pans, which were hermetically 
sealed, then the lid was pierced. Each sample was measured in the temperature interval of 25 
°C – 300 °C at a heating rate of 5 °C min-1 under constant argon flow of 150 mL min-1. 
2.6 Fourier-transform infrared spectroscopy (FT-IR)
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FTIR spectrum of each sample was obtained by using Fourier transform infrared spectroscopy 
(Thermo Nicolet AVATAR 330, USA) equipped with GRAMS/AI Version 7.00 software. The 
samples were ground with 150 mg dry KBr in a mortar and pestle, then compressed into a disc 
at 10 t pressure. The discs were scanned 128 times at a resolution of 4 cm-1 over                        
4000-400 cm-1 wavenumber region.
2.7 X-ray powder diffraction (XRPD)
The crystalline phase of LOR, PM, SE, and LOR-NFs was characterized using an X-ray powder 
diffraction (XRPD) BRUKER D8 Advance X-ray diffractometer (Bruker AXS GmbH, 
Karlsruhe, Germany) with Cu K λI radiation (λ = 1.5406 Å) and a VÅNTEC-1 detector. The 
powder samples were scanned at 40 kV and 40 mA, with an angular range 3° to 40° 2θ, at a 
step time of 0.1 s and a step size of 0.02°r.
Eva software was used to separate the crystal and related amorphous peaks. Thus, the software 
calculated the values of the integrated intensities of the amorphous and crystalline contribution 
and the crystalline-only contribution. The crystallinity index values (Xc) of the samples were 
calculated based on the following equation:
(1)𝑋𝑐 = 𝐴𝑐𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑒 𝐴𝑐𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑒 +  𝐴𝑎𝑚𝑜𝑟𝑝ℎ𝑜𝑢𝑠
2.8 Dissolution studies
Modified paddle method (USP dissolution apparatus, type II Pharma Test, Hainburg, Germany) 
was used to determine the rates of dissolution of LOR, PM, SE, and LOR-NFs. Samples 
containing 1.11 mg of loratadine were placed in 100 mL of phosphate buffer solution at pH 7.4. 
The paddles were rotated at 100 rpm at 37 °C. At predetermined time 5 m aliquot was 
withdrawn, filtered and measured for loratadine content using UV spectrophotometry (Unicam 
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UV/VIS Spectrophotometer, Cambridge, UK) at max 248nm. The sampling was performed for 
120 min.
2.9 Model-independent kinetics of dissolution profiles
The dissolution behavior of the samples was characterized by calculating the dissolution 
efficiency (DE) at different time points. The DE represents the percentage of the ratio of the 
area up to time t divided by the area that described 100% dissolution at the same time (Khan, 
1975):
(2)%𝐷𝐸 = (∫𝑡0𝑦 𝑋 𝑑𝑡) (𝑦100 𝑋 𝑡) × 100%
The relative dissolution (RD) at 60 min was calculated relative to LOR by using the following 
formula:
(3)𝑅𝐷60 𝑚𝑖𝑛 = % 𝐷𝐸60 𝑚𝑖𝑛 % 𝐷𝐸60 𝑚𝑖𝑛
The area under the curve (AUC) was calculated by the trapezoidal method. AUC represents the 
sum of all trapezia:
(4)𝐴𝑈𝐶 = ∑𝑖 = 𝑛𝑖 = 1[(𝑡1 ‒ 𝑡𝑖 ‒ 1)(𝑦𝑖 ‒ 1 + 𝑦𝑖) 2]
Where ti represents the time point and yi is the percentage of sample dissolved at time ti. The 
mean dissolution time (MDT) was calculated using the following formula (Costa, P., & Lobo, 
2001)
(5)𝑀𝐷𝑇 = ∑𝑛𝑖 ‒ 1𝑡𝑚𝑖𝑑∆ 𝑀 ∑𝑛𝑖 ‒ 1∆ 𝑀
Where i is the dissolution sample number, n is the number of dissolution times, tmid is the time 
at the midpoint between times ti and ti−1, and ΔM is the amount of the dissolved drug (mg) 
between times ti and ti−1.
3. Results and discussion 
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3.1 Morphology and diameter of the LOR-NFs
Smooth LOR nanofibers without the presence of beads were obtained from the electrospinning 
of PVP alcohol solutions (Figure 2c and 2d). The collection distance had a significant effect on 
the diameter of the prepared nanofibers. 95 mm collection distance resulted in the formation of 
smooth nanofibers with small diameter (372 ± 181 nm). The low diameter indicates that the 
nanofibers were stretched enough and sufficiently dried before deposition on the collector. On 
the other hand, large diameter and fused fibers were obtained at the shorter collection distance 
(65 mm). The nanofibers in this experiment (LOR-NF1) appeared to not well featured and fused 
as an indication of the incomplete drying. Furthermore, the protruded fiber shows a large 
diameter (948 ± 234 nm) and plasticized shape as another indication of not complete drying. 
The PM showed the characteristic crystal of LOR that showed a crystal size larger than 2 μm 
(Figure 2a). The SE showed irregular shapes of LOR crystal, both short rod and prisms were 
present. Moreover, the rod shape crystals exhibited a diameter of 562.7 ± 379 nm. The image 
of SE (Figure 2b) also showed the aggregation and variety of distribution of LOR within the 
matrix of PVP polymer.
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Figure 2. Scanning electron microscopy images of the (a) physical mixture; (b) sample 
prepared by solvent evaporation; (c) electrospun nanofibers using the working distance of 65 
mm (LOR-NF1); (d) electrospun nanofibers using the working distance of 95 mm (LOR-NF2). 
The SEM image (d) shows separated, more uniform and smaller diameter nanofibers compared 
to (c). 
3.2 Structural analysis (DSC, XRPD, and FT-IR)
The DSC thermogram of LOR exhibited a sharp endothermic peak at 136.65 °C corresponding 
to its melting point. The filament-forming matrix polymer PVP showed a broad endotherm 
between 50 and 100 °C with a peak at 90 °C related to dehydration. The PM and SE showed 
the characteristic peak of LOR indicating the presence of LOR in its crystalline status. However, 
these endothermic peaks showed a lower intensity compared to pure LOR due to the reduction 
of crystallinity either by the dilution effect (PM) and/or the preparation method (SE). DSC of 
LOR-NFs exhibited a broad peak at temperatures lower than 60 °C, primarily caused by the 
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thermal effect of moisture evaporation and also the glass transition. Moreover, the endothermic 
peak of LOR has disappeared in the prepared NFs indicating that LOR was no longer present 
as a crystalline, but had been converted into an amorphous state (Figure 3) (Akhgari et al., 
2016). 
Figure 3. DSC thermograms of the raw materials, reference samples and the prepared 
nanofibers. The reference samples (PM and SE) show the melting point of LOR while 
electrospun nanofibers represent the amorphous nature of the LOR.
The X-ray diffraction patterns of the LOR, PVP, PM, LOR-NF1, and LOR-NF2 are presented 
in Figure 4. LOR showed numerous peaks between 3-30 of the 2-θ scale indicated that LOR is 
present as a crystalline material. PVP showed two broad halo peaks specified to amorphous 
status. PM showed the same characteristic peaks of pure LOR while SE showed the lower 
intensity of LOR peaks in addition to the absence of many peaks due to the reduction of the 
crystallinity. LOR-NF1 and LOR-NF2 showed complete disappearance of LOR characteristic 
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peaks. However, the two halo peaks of PVP were observed in the electrospun fibers at the same 
position and showed the same shape.
Figure 4. XRPD diffractograms of the raw materials, reference samples and the prepared 
nanofibers. The electrospun nanofiber samples were amorphous, while the reference samples 
(PM and SE) show the crystalline peaks of LOR.
The crystallinity index (XC) values were calculated to reveal the changes in the degree of 
crystallinity of the LOR nanofibers and SE with respect to the PM (Gombás et al., 2002). The 
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crystallinity indices from XRPD and DSC further suggest the amorphous state of the prepared 
LOR-NFs (Table 2). The nominal values of XC obtained from DSC curves were different from 
that found by XRPD measurements for the samples. The differences in the measurements were 
expected because of using comparative methods to obtain data rather than absolute ones (Tserki 
et al., 2006). In the case of XRPD, the XRPD patterns were separated by the software into 
crystalline and amorphous peaks, and the degree of crystallinity was estimated based on 
equation (1). In spite of the qualitative analysis of the amorphous peaks by this method, the 
same procedure was applied to all samples in order to get comparable values. On the other hand, 
the values obtained by DSC were based on the heat of fusion. Both methods represented the 
variation of crystallinity between the prepared samples.
Table 2. The calculated crystallinity index (Xc) of the reference samples and the 
prepared nanofibers after DSC and XRPD measurements compared to LOR.
Crystallinity index (%)Sample 
XRPD DSC
SE 32.71 47.29
LOR-NF1 30.28 0.93
LOR-NF2 9.79 0.93
FT-IR analysis was performed to check the compatibility and interactions between LOR and 
the nanofiber matrix (Figure 5). The FTIR bands that are characteristic to LOR are located at 
997 cm−1 for aryl C-Cl stretching and 1,227cm−1 for -C-N stretching of aryl N. In addition to 
bands at 1560 and 1703 cm−1 corresponded to C-O bonds of the amide or ester groups. Bands 
from 3000 to 2850 cm−1 correspond to the C-H bond (Alshweiat et al., 2018). On the other 
hand, PVP showed its characteristic bands at 3448.3 cm−1 due to O-H stretching vibrations, 
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2924.4 cm−1 related to asymmetric stretching of CH2, 1652.3 cm−1 for C=O stretching and a 
broad peak at 1289.4 cm−1 due to C-N stretching vibrations (Sriyanti et al., 2018). The FTIR 
spectra of the physical mixture and the reference sample showed no obvious shift of the peaks 
of the functional groups corresponding for hydrogen bonding. However, LOR-NF samples 
showed shifted peaks of LOR and PVP. The main effects were observed in the O-H and C=O 
regions. The hydroxyl peak of PVP at 3448.3 cm−1 shifted to 3512 cm−1 and the C=O stretching 
peaks at 1652.3 cm−1 shifted to 1666.5 cm−1. The band of LOR shifted from 1702.8 to 1666.5 
overlapping with the shifted peak of PVP. The peak shift of carbonyl stretching was thought to 
be a result of hydrogen bond intermolecular interaction between LOR and PVP (Zhao et al., 
2017). Since the FTIR results showed only hydrogen bonding, but no covalent bonding,  LOR 
and PVP as nanofibers are indicated to be compatible with each other (Frizon et al., 2013; John 
et al., 2002).
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Figure 5. FT-IR spectra of the raw materials, reference samples and the prepared electrospun 
nanofibers. The electrospun nanofiber samples and SE sample show an intermolecular 
interaction between LOR and PVP via hydrogen bond formation.
According to the aforementioned characteristics of the LOR-NFs, only the LOR-NF2 showed 
the complete separation of the fibers and nanofibers with small diameters. Therefore, it was 
selected for further solubility and dissolution studies.
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3.3 Solubility and Dissolution studies
LOR-NF2 showed a 26.2-fold increase of LOR solubility compared to the pure drug in 
phosphate buffer solution, pH 7.4. The solubility of LOR-NF2 was 13.1 ± 0.26 µg mL-1 
compared to 0.50 ± 0.11 μg mL-1 for LOR at 25 °C (Table 3). The dissolution behaviors of the 
samples are shown in Figure 6. LOR-NF2 showed the highest release rate, more than 66% of 
the drug was released in the first 10 min compared to less than 0.5% of the pure LOR. SE 
samples also showed higher dissolution than LOR because of their contact with the hydrophilic 
polymer. However, the PM exhibited a release behavior similar to LOR. The improvement in 
the dissolution of LOR from the electrospun fibers was attributed to the presence of LOR in the 
amorphous state. Loratadine has been reported to have higher kinetic energy in the amorphous 
state, hence higher dissolution than its crystalline state. Moreover, the three-dimensional 
structure of the electrospun fiber can offer a larger surface area, therefore, water can diffuse 
more efficiently into the polymer to dissolve the drug. The dissolution efficiency of LOR-NF2 
was enhanced at all selected time points, as well as RD value. The mean dissolution time of 
LOR-NF2 was decreased. These results confirmed that the dissolution became fast due to the 
amorphous state of the drug in the nanofibers, presence of the additives, and reduction of the 
particle size. The calculated DE, MDT, and RD are shown in Table (4).
Table 3. Solubility (µg mL-1) of LOR and the prepared samples in phosphate 
buffer at pH 7.4 at a temperature of 25 °C.
Sample Solubility (µg mL-1)
LOR 0.50 ± 0.11
PM 6.45 ± 0.06
SE 7.58 ± 0.38
LOR-NF2 13.1 ± 0.11
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Figure 6. Dissolution behavior of LOR, reference samples and the prepared electrospun 
nanofiber with working distance 6.5 mm in phosphate buffer solution, pH 7.4. The nanofiber-
based sample has improved dissolution kinetics and higher dissolution rates than the raw LOR 
or the reference samples (PM and SE).
Table 4. Dissolution efficiency (DE) at different time points, mean dissolution time (MDT), 
and relative dissolution (RD), with respect to the raw LOR at 60 min of the samples. 
Sample %DE30 %DE60 %DE120 MDT RD60
LOR 1.47 3.73 4.60 36.69 -
PM 0.69 1.46 3.45 53.63 0.39
SE 5.64 7.06 8.54 13.28 1.89
LOR-NF2 61.2 70.89 75.52 5.87 19.0
4. Conclusion 
This study demonstrated the use of a low-cost 3D-printed electrospinning device with counter-
flow air stream for the generation of nanofibers using a rotating metal drum as a collector. 
Nanofibers of LOR were prepared in the hydrophilic PVP polymer and compared to the 
corresponding physical mixture and conventional reference sample, that was prepared by the 
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solvent evaporation method. The distance between the nozzle and collecting drum was an 
influential process-parameter; it affected the possibility of preparing separated nanofibers. 
Moreover, it affected the diameters of the nanofibers. 65 mm distance was optimum to produce 
separated nanofibers with diameters of 372 nm. The prepared nanofibers displayed an 
amorphous status of LOR, and the spectroscopic studies indicated interactions between the drug 
and polymer. As a result of the formation of the amorphous nanofibers, the solubility and 
dissolution of LOR were enhanced. Solubility studies showed a marked increase in release rate 
compared to the pure drug. LOR-NF2 showed a 26.2-fold increase in the solubility of LOR as 
compared to the pure drug in phosphate buffer solution, pH 7.4. Moreover, more than 66% of 
the drug was released in the first 10 min compared to less than 4% drug release from the 
conventional reference sample (SE). Therefore, faster and higher dissolution was achieved for 
the poorly water-soluble LOR by fabrication of electrospun nanofibers. The improved 
dissolution properties could enable the design of new alternative loratadine formulations, 
including buccal, transdermal, and topical dosage forms. 
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